Uniswift Pharmaceuticals Private Limited

Uniswift Pharmaceuticals Private Limited - trading in Madiwala, Karnataka, India. FY 2026 financials & compliance.
CIN U51909KA2019PTC129263 Incorporated 01 November 2019 ROC Bangalore HQ Madiwala, Karnataka, India
Active Private Limited Company trading
Data last updated
Revenue · FY 2021
₹20.35 Lakh
▲ 405% YoY
Net loss · FY 2021
₹5.93 Lakh
Net margin -29.1%
EBITDA · FY 2021
-₹5.58 Lakh
EBITDA margin -27.4%
Authorised capital
₹10 Lakh
Registered with MCA
Paid-up capital
₹8 Lakh
Issued & subscribed
Company age
7 yrs
Est. 2019
Directors on board
4
As per MCA filings
Active GSTINs
1
GST registered

About Uniswift Pharmaceuticals Private Limited

Data last updated:

Uniswift Pharmaceuticals Private Limited is a private limited company based in Madiwala, Karnataka, India. It operates in the specialised services segment of the trading and commerce sector. It was incorporated on 01 November 2019 and has been in existence for over 7 years.

The company is registered with the Registrar of Companies (ROC), Bangalore, under CIN U51909KA2019PTC129263. Its GSTIN is 32AACCU5115H1ZP (Kerala).

The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹8 Lakh. It is led by directors including Perinkulam Krishnan Krishnan (Managing Director) and Kochiyil Vijayan.

Its last annual general meeting (AGM) was held on 30 November 2021, and its latest financial statements are for the year ended 31 March 2021. The registered office is at Door No.11 4th B Cross Road Maruthi Nagar, Madiwala, Karnataka, India – 560068.

As per the financials filed for FY 2021, the company reported a revenue of ₹20.35 Lakh, reflecting significant growth compared to the previous year. For the same year it recorded a net loss of ₹5.93 Lakh (net margin -29.1%) and EBITDA of -₹5.58 Lakh (EBITDA margin -27.4%).

Company details

CIN U51909KA2019PTC129263
Registration Number 129263
Incorporation Date 01 November 2019
ROC Bangalore
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 November 2021
Date of Balance Sheet 31 March 2021

Contact details

Uniswift Pharmaceuticals Private Limited's registered office is in Madiwala, Karnataka. Its e-mail address is in the company report.

  • Email
  • Registered Address
    Door No.11 4th B Cross Road Maruthi Nagar, Madiwala, Karnataka, India – 560068
  • Industry
    Trading, Specialty, Wholesale

To see the full contact details of Uniswift Pharmaceuticals Private Limited, buy the company report.

Comprehensive company report
Uniswift Pharmaceuticals Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Business activity

The main business activity of Uniswift Pharmaceuticals is trade. In detail, this covers wholesale trading.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
GTradeG1Wholesale Trading

To see the full business activity and turnover split of Uniswift Pharmaceuticals Private Limited, buy the company report.

Financials of Uniswift Pharmaceuticals Private Limited

FY 2021 filings available

Uniswift Pharmaceuticals Private Limited reported revenue of ₹20.35 Lakh (up 405% YoY) for FY 2021.

Revenue · FY 2021
₹20.35 Lakh ▲ 405%
Net loss · FY 2021
₹5.93 Lakh margin -29.1%
EBITDA · FY 2021
-₹5.58 Lakh margin -27.4%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▲ 405%
EBITDA CAGR growth
1 year
▼ 83%

Revenue rose 405% in the latest year. EBITDA fell 83% in the latest year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2020-21FY 2019-20
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA-₹5.58 Lakh
Profit Before Tax
Tax Expense
Net Profit (PAT)-₹5.93 Lakh
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2020-21FY 2019-20
Profitability
EBITDA Margin-27.4%
Net Profit Margin-29.1%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Uniswift Pharmaceuticals Private Limited, buy the company report.

Board of directors of Uniswift Pharmaceuticals Private Limited

Uniswift Pharmaceuticals has 4 current directors and 4 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Kochiyil VijayanDirector11 Mar 20224 Years 7 MonthsCurrent
Perinkulam Krishnan KrishnanManaging Director01 Nov 20196 Years 11 MonthsCurrent
Ramakrishnan Mathirat MadhusoodananDirector01 Nov 20196 Years 11 MonthsCurrent
Kangaparambil Sankaranaryanan ManojDirector11 Mar 20224 Years 7 MonthsCurrent

Peer comparison

Uniswift Pharmaceuticals Private Limited is compared with the 3 companies closest to it by revenue in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
Keyares Pharmaceuticals Private Limited₹20.42 Lakh (FY 2022)Patna, Bihar, India
Descant Pharmaceuticals Private Limited₹20.41 Lakh (FY 2024)-18.0%Unnao, Uttar Pradesh, India
Uniswift Pharmaceuticals Private Limitedthis company₹20.35 Lakh (FY 2021)-₹5.93 Lakh-29.1%405.0%Madiwala, Karnataka, India
Ecovision Pharmaceuticals Private Limited₹20.19 Lakh (FY 2023)-26.0%Patna, Jharkhand, India

To see the full peer comparison of Uniswift Pharmaceuticals Private Limited, buy the company report.

MSME payment delays

No delayed payments to MSME suppliers are on our record for Uniswift Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

GST

Uniswift Pharmaceuticals has 1 GST registration: 1 active.

Total GSTINs
1
Active
1
GSTINStateStatusRegistered on
32AACCU5115H1ZPKeralaActive28 Jan 2020

To see the full GST registrations and return filing status of Uniswift Pharmaceuticals Private Limited, buy the company report.

Recent activity

Uniswift Pharmaceuticals Private Limited has 8 board changes on record since 2019: 4 appointments and 4 cessations. The latest: Kangaparambil Sankaranaryanan Manoj was appointed as Director on 11 Mar 2022.

Appointed
Kangaparambil Sankaranaryanan Manoj was appointed as Director.
Appointed
Kochiyil Vijayan was appointed as Director.
AGM
Uniswift Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Nov 2021 as per latest MCA records.
Ceased
Cheriya Palam Manikandan ceased to be Director.
Filing
Uniswift Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2021 with Roc Bangalore.
Ceased
Perinkulam Krishnan Krishnan ceased to be Director.
Ceased
Ramakrishnan Mathirat Madhusoodanan ceased to be Managing Director.
Ceased
Sandhra Manoj ceased to be Additional Director.
Appointed
Perinkulam Krishnan Krishnan was appointed as Managing Director.
Appointed
Ramakrishnan Mathirat Madhusoodanan was appointed as Director.
Incorporation
01 Nov 2019
Uniswift Pharmaceuticals Private Limited was registered on 01 Nov 2019 with Roc Bangalore & aged 6 years 11 months as per MCA records.

Frequently asked questions

Uniswift Pharmaceuticals is an active private limited company based in Madiwala, Karnataka, India. The company works in specialty, within the trading industry. It was incorporated on 01 November 2019 (7+ years old) and is registered under CIN U51909KA2019PTC129263.

Uniswift Pharmaceuticals has 4 current directors:

The latest financial statements of Uniswift Pharmaceuticals on record with the MCA are for the year ended 31 March 2021. Its last annual general meeting was held on 30 November 2021. Year-wise statements from FY 2020 are in the company report.

The GSTIN of Uniswift Pharmaceuticals is 32AACCU5115H1ZP, registered in Kerala.

The CIN (Corporate Identification Number) of Uniswift Pharmaceuticals is U51909KA2019PTC129263. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Uniswift Pharmaceuticals was incorporated on 01 November 2019, making it 7+ years old. It is registered with the Registrar of Companies, Bangalore.

The peers of Uniswift Pharmaceuticals by revenue are Keyares Pharmaceuticals Private Limited, Descant Pharmaceuticals Private Limited, Ecovision Pharmaceuticals Private Limited, all in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading).

Kangaparambil Sankaranaryanan Manoj was appointed as Director on 11 Mar 2022. Kochiyil Vijayan was appointed as Director on 11 Mar 2022. Cheriya Palam Manikandan ceased to be Director on 08 Jul 2021. Uniswift Pharmaceuticals has 8 board changes on record in total.

The registered office of Uniswift Pharmaceuticals is at Door No.11 4th B Cross Road Maruthi Nagar, Madiwala, Karnataka, India – 560068.

Uniswift Pharmaceuticals operates in the trading industry, in the specialty segment.

Uniswift Pharmaceuticals can be reached at its registered office: Door No.11 4th B Cross Road Maruthi Nagar, Madiwala, Karnataka, India – 560068.